Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Pet bed
Semiconductor device with hetero-junction bodies
Using network labels without standard-defined syntax and semantics
Integrated emergency medical database system
Information processing apparatus and update information obtainment method
State detection device, electronic apparatus, measurement system and program
Segmenting video based on timestamps in comments
  Randomly Featured Patents
System and method for finding persons in a corporate entity
Exposure apparatus, exposure method, and method for producing device
Level shifter and driving method
Roots vacuum pump
Camomile oils having a high natural poly-ynes content and process for their production
Microwave oven
Assembly for cleaning toner resin from a printing device and method
Volume-loaded short dipole antenna
Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
Reduced absorption of fatty acids